Secondary Prevention of Venous Thromboembolism with the Oral Direct Thrombin Inhibitor Ximelagatran von Schulman, Sam, Wåhlander, Karin, Lundström, Torbjörn, Clason, Solveig Billing, Eriksson, Henry

Volltext

Development of Human Target Validation Classification that Predicts Future Clinical Efficacy von Karlsson, Cecilia, Greasley, Peter J, Gustafsson, David, Wåhlander, Karin

Volltext

Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: a randomized dose-guiding, safety, and... von Lip, Gregory Y.H., Rasmussen, Lars H., Olsson, S. Bertil, Jensen, Eva C., Persson, Anders L., Eriksson, Ulf, Wåhlander, Karin F.C.

Volltext

Trousseau’s syndrome – what is the evidence? A population-based autopsy study von ÖGREN, Mats, BERGQVIST, David, WAHLANDER, Karin, ERIKSSON, Henry, STERNBY, Nils H

Volltext

Safety and tolerability of an immediate-release formulation of the oral direct thrombin inhibitor AZD0837 in the prevention of stroke and systemic embolism in patients with atrial... von Olsson, Bertil S., Rasmussen, Lars H., Tveit, Arnljot, Jensen, Eva, Wessman, Peter, Panfilov, Seva, Wåhlander, Karin

Volltext

Effect of recombinant factor VIIa on melagatran-induced inhibition of thrombin generation and platelet activation in healthy volunteers von Wolzt, Michael, Levi, Marcel, Sarich, Troy C., Boström, Stig L., Eriksson, Ulf G., Eriksson-Lepkowska, Maria, Svensson, Mia, Weitz, Jeffrey I., Elg, Margareta, Wåhlander, Karin

Volltext

Exposure–response for biomarkers of anticoagulant effects by the oral direct thrombin inhibitor AZD0837 in patients with atrial fibrillation von Lip, Gregory Y. H., Rasmussen, Lars H., Olsson, S. Bertil, Jensen, Eva, Hamrén, Bengt, Eriksson, Ulf G., Wåhlander, Karin

Volltext

Histone deacetylase inhibitors stimulate tissue-type plasminogen activator production in vascular endothelial cells von Larsson, Pia, Bergh, Niklas, Lu, Emma, Ulfhammer, Erik, Magnusson, Mia, Wåhlander, Karin, Karlsson, Lena, Jern, Sverker

Volltext

Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: A Phase II study of AZD0837 in patients... von Lip, Gregory Y.H, Rasmussen, Lars H, Olsson, S. Bertil, Zetterstrand, Sofia, Stahre, Christina, Bylock, Anders, Aunes-Jansson, Maria, Eriksson, Ulf, Wåhlander, Karin

Volltext

Mim8 Clinical Development Program: An Overview of the Frontier Studies von Seremetis, Stephanie Valer, Clausen, Wan Hui Ong, Matytsina, Irina, Nissen, Susanne Møller, Wåhlander, Karin

Volltext

Prognostic factors for recurrence of venous thromboembolism (VTE) or bleeding during long-term secondary prevention of VTE with ximelagatran von Eriksson, Henry, Lundström, Torbjörn, Wåhlander, Karin, Billing Clason, Solveig, Schulman, Sam

Volltext

Effect on perfusion chamber thrombus size in patients with atrial fibrillation during anticoagulant treatment with oral direct thrombin inhibitors, AZD0837 or ximelagatran, or with... von Wolzt, Michael, Eriksson, Ulf G, Gouya, Ghazaleh, Leuchten, Nicolai, Kapiotis, Stylianos, Elg, Margareta, Schützer, Kajs-Marie, Zetterstrand, Sofia, Holmberg, Malin, Wåhlander, Karin

Volltext

Effects of IL-1β and IL-6 on tissue-type plasminogen activator expression in vascular endothelial cells von Larsson, Pia, Ulfhammer, Erik, Karlsson, Lena, Bokarewa, Maria, Wåhlander, Karin, Jern, Sverker

Volltext

Reversible elevations of serum creatinine levels but no effect on glomerular filtration during treatment with the direct thrombin inhibitor AZD0837 von Schützer, Kajs-Marie, Svensson, Maria K, Zetterstrand, Sofia, Eriksson, Ulf G, Wåhlander, Karin

Volltext

Glucose-stimulated Insulin Biosynthesis Depends on Insulin-stimulated Insulin Gene Transcription von Leibiger, Barbara, Wåhlander, Karin, Berggren, Per-Olof, Leibiger, Ingo B.

Volltext

Antithrombotic effects of ximelagatran plus acetylsalicylic acid (ASA) and clopidogrel plus ASA in a human ex vivo arterial thrombosis model von Karin Wåhlander, Maria Eriksson-Lepkowska, Per Nyström, Ulf G. Eriksson, Troy C. Sarich, Juan J. Badimon, Inge Kalies, Margareta Elg, Anders Bylock

Volltext

Effect of Melagatran on Prothrombin Time Assays Depends on the Sensitivity of the Thromboplastin and the Final Dilution of the Plasma Sample von Mattsson, Christer, Menschiek-Lundin, Angela, Wåhlander, Karin, Lindahl, Tomas L.

Volltext

No influence of mild-to-moderate hepatic impairment on the pharmacokinetics and pharmacodynamics of ximelagatran, an oral direct thrombin inhibitor von WAHLANDER, Karin, ERIKSSON-LEPKOWSKA, Maria, FRISON, Lars, FAGER, Gunnar, ERIKSSON, Ulf G

Volltext

Pharmacokinetics, pharmacodynamics and clinical effects of the oral direct thrombin inhibitor ximelagatran in acute treatment of patients with pulmonary embolism and deep vein thro... von Wåhlander, Karin, Lapidus, Leif, Olsson, Carl-Gustav, Thuresson, Anneli, Eriksson, Ulf G, Larson, Göran, Eriksson, Henry

Volltext

Consistent pharmacokinetics of the oral direct thrombin inhibitor ximelagatran in patients with nonvalvular atrial fibrillation and in healthy subjects von WOLZT, Michael, WOLLBRATT, Maria, SVENSSON, Mia, WAHLANDER, Karin, GRIND, Margaretha, ERIKSSON, Ulf G

Volltext